Author: Brindle Editorial

The appaloosa pattern (the spotted, blanket, and roaning phenotypes collectively associated with the Appaloosa breed and the LP locus) has a confirmed molecular basis in the TRPM1 gene. It is the only major horse coat pattern where the causal gene also produces a sensory deficit: horses homozygous for the leopard complex allele (LP/LP) are night-blind. The same gene, in the same tissues, produces the pattern and the visual impairment. This makes the LP complex an unusually instructive case for understanding how coat patterning genes can have off-target effects, a phenomenon also seen in the IKBKG mutation underlying incontinentia pigmenti and in the EDNRB frame overo lethal white syndrome.

The LP allele and TRPM1

The leopard complex (LP) locus was mapped to equine chromosome 1 (ECA1) by Sponenberg in 1982 and later refined by linkage studies. The causal gene was identified as TRPM1 (transient receptor potential cation channel, subfamily M, member 1) by two independent groups in 2013. Bellone RR, et al., PLoS One, 2013;8(7):e68195. doi:10.1371/journal.pone.0068195 demonstrated that an insertion in the promoter region of TRPM1 disrupts normal gene expression in melanocytes and retinal cells in horses carrying the LP allele. The insertion is a retrotransposon-derived element that alters transcription factor binding, reducing TRPM1 expression in the specific cell types where it is normally active.

TRPM1 encodes a calcium-permeable ion channel expressed in melanocytes (where it affects pigmentation) and in the retinal ON-bipolar cells of the eye (where it is essential for the transmission of visual signals from rod photoreceptors in low-light conditions). Reduced TRPM1 expression in melanocytes produces the characteristic coat dilution and spotting; reduced expression in the retina impairs night vision. OMIA:001890-9796 (Congenital stationary night blindness, Equus caballus) records the causal variant as confirmed for the visual phenotype; OMIA:000301-9796 records the appaloosa coat pattern association.

Genotype and phenotype: LP and PATN1

The LP complex requires at least two loci to explain the full range of appaloosa phenotypes. LP (the TRPM1 allele) is necessary but not sufficient for the leopard (spotted) phenotype; a second, unlinked locus called PATN1 modifies the extent of patterning. Horses with one copy of LP and no PATN1 modifier show a “varnish roan” or “blanket” phenotype: a speckled or blanket effect concentrated over the croup, without discrete spots. Horses with LP plus one or two copies of PATN1 show more extensive spotting (leopard or near-leopard patterns). The interaction between LP and PATN1 is the primary determinant of how spotted an appaloosa-pattern horse appears. Druml T, Seltenhammer MH, Curik I, et al., Mamm Genome, 2013 documented the PATN1 effects in Noriker horses.

Homozygosity for LP (LP/LP) produces both more extensive white patterning and complete congenital stationary night blindness (CSNB). The horse is not otherwise impaired but cannot see in low-light conditions. Because LP/LP horses are produced predictably from LP/+ x LP/+ crosses, the night-blindness risk is relevant to breeding decisions in appaloosa-heavy programs. A DNA test identifying LP zygosity is commercially available and allows breeders to predict both coat pattern extent and CSNB risk in foals.

Physical features of the LP complex phenotype

The appaloosa coat pattern includes several visually consistent features that persist regardless of base coat color:

• Mottled skin: irregular pink-and-dark patches on unpigmented skin around the muzzle, eyes, and genitalia. Visible in foals and stable throughout life.
• Striped hooves: vertical dark-and-light striping on the hoof wall. Not diagnostic on its own (other patterns can produce it) but consistent in LP-carrying horses.
• White sclera: the area surrounding the iris is white, giving the eye a more human-like appearance. Present in most LP carriers.
• Sparse mane and tail: thinner, less dense mane and tail hair than non-LP horses, a feature especially visible in the Knabstrupper and other appaloosa-type breeds.

These secondary characteristics, particularly mottled skin and white sclera, appear even in minimally expressed LP horses and are used by experienced appraisers as a supplementary check when coat pattern alone is ambiguous. The Appaloosa Horse Club requires documentation of at least one of these features (plus coat pattern) for registration as an appaloosa.

Why appaloosa spots are not brindle stripes

Appaloosa spots and brindle stripes are occasionally conflated in informal horse description, particularly in breeds that carry both coat color variation and complex patterning. The distinction is mechanistic and visual. Brindle produces vertical stripes that follow Blaschko’s lines (the developmental migration paths of skin cells) and is either non-heritable (chimeric brindle, somatic mosaicism brindle) or heritable through the BR1 (MBTPS2) X-linked variant. Appaloosa spots are patches of depigmented skin produced by TRPM1 downregulation during embryonic development, with a genetic basis entirely different from any of the brindle mechanisms. A spotted appaloosa horse can be confirmed by LP genotyping; a brindle horse does not carry LP alleles and does not show mottled skin or white sclera.

Sources

• Bellone RR, Brooks SA, Sandmeyer L, Murphy BA, Forsyth G, Archer S, Bailey E, Grahn B. Differential gene expression of TRPM1, the potential cause of congenital stationary night blindness and coat spotting patterns (LP and PATN1) in the horse (Equus caballus). Genetics. 2008;179(4):1861-70. PubMed.
• Bellone RR, Holl H, Setaluri V, Devi S, Maddodi N, Archer S, et al. Evidence for a retroviral insertion in TRPM1 as the cause of congenital stationary night blindness and leopard complex spotting in the horse. PLoS One. 2013;8(7):e68195. PMC3714269.
• OMIA:001890-9796: Congenital stationary night blindness, Equus caballus. Accessed 2026-06-04.
• OMIA:000301-9796: Coat colour, leopard complex, Equus caballus. Accessed 2026-06-04.
• Sponenberg DP, Bellone R. Equine Color Genetics. 4th ed. Wiley Blackwell; 2017. pp. 161–200 (appaloosa and LP complex).

Frame overo is the only white-spotting pattern in horses that kills foals at a predictable Mendelian frequency. A horse heterozygous for the frame allele carries a distinctive white pattern with irregular borders, horizontal spread, and consistently dark legs; a horse homozygous for the same allele is born white, alive, and dead within days from an enteric nervous system defect. The gene responsible is EDNRB. The mechanism is among the best-characterized in equine coat genetics, and understanding it has direct implications for breeding management and for understanding why coat pigmentation genes are often pleiotropic, affecting not just color but organ systems derived from the same embryonic tissue.

The EDNRB mutation

Frame overo is caused by a single nucleotide variant in the endothelin receptor type B gene (EDNRB): a missense substitution at codon 118, Ile→Lys (c.353T>A, p.Ile118Lys). Yang GC, Croaker D, Zhang AL, et al., Hum Mol Genet, 1998;7(4):795–801 and subsequent work by Metallinos DL, Bowling AT, Rine J., Mamm Genome, 1998;9(5):426–431 established the missense variant as the cause of the paint/pinto frame pattern and the associated lethal white foal syndrome. The same variant in homozygous form causes complete aganglionosis of the distal intestine: the enteric neurons fail to populate the gut during fetal development, producing a functional bowel obstruction that is incompatible with life. The foal is white because melanocytes, like enteric neurons, are derived from the neural crest, and EDNRB signaling is required for both cell populations to migrate correctly from the neural crest to their target tissues. OMIA:000409-9796 (Coat colour, frame overo, Equus caballus) records the causal variant as confirmed.

Genetics of inheritance

The frame overo allele (O) is dominant for the coat pattern and recessive for the lethal phenotype. This is not a paradox: one copy of the mutant allele reduces EDNRB signaling enough to alter melanocyte migration in a spatially restricted way, producing the characteristic frame pattern; two copies reduce signaling to the point where enteric neuron migration fails entirely. The consequence for breeding:

• O/+ (heterozygote): frame-patterned horse, normal gut function, carrier of the allele.
• O/O (homozygote): born white (lethal white foal), dies within 72 hours from intestinal aganglionosis.
• +/+ (non-carrier): no frame pattern, no lethal risk.

Frame x frame matings produce a 1:2:1 ratio of non-frame, frame, and lethal-white foals. The 25% lethal-white rate is a predictable outcome of this cross. Registries and breed associations in the paint and pinto world universally discourage frame x frame matings for this reason. A DNA test for the EDNRB variant is available commercially and is the standard method for identifying carriers before breeding decisions are made.

What frame overo looks like

Frame overo has a visually consistent character that distinguishes it from tobiano and from splash white. The white pattern tends to stay on the sides and belly rather than crossing the topline. The edges of the white are ragged and irregular (often described as having a “lacy” or “splattered” border) rather than the smooth, rounded edges of tobiano patches. The legs are typically dark (not white), and the tail is typically the base coat color. The head often shows a large, irregular blaze that may extend to cover much of the face. In a minimally expressed frame horse, the white may be confined to the belly with little visible from the side.

The term “overo” is used loosely in many registries to mean “not tobiano,” encompassing frame, splash white, and sabino under one label. This is genetically imprecise; only frame overo is caused by the EDNRB variant, and only frame overo carries the lethal homozygote risk. Splash white is caused by MITF mutations and does not produce lethal-white foals. Sabino-1 is a KIT splice-site variant with its own characteristics. When breeders say “overo” they often mean frame, but the DNA test is the only way to know for certain.

EDNRB and the neural crest connection to coat patterning

The neural crest is an embryonic cell population that migrates away from the dorsal neural tube during development and differentiates into a remarkable diversity of cell types: peripheral neurons, Schwann cells, craniofacial cartilage, adrenal medulla cells, and melanocytes. Because so many cell types share this origin, mutations in genes governing neural crest migration (including EDNRB, KIT, and MITF) often produce what appear, at first glance, to be “coat color genes” but are in reality general migration and differentiation regulators with broad developmental roles. The lethality in frame-overo homozygotes is the most visible consequence of this in the horse. In Hirschsprung disease in humans, loss-of-function mutations in EDNRB produce the same intestinal aganglionosis without any coat phenotype (humans don’t have melanocyte-dependent coat patterns in the same way), illustrating that the gut and skin effects of EDNRB are separable and context-dependent. McCallion AS and Chakravarti A, Hum Mol Genet, 2001 reviewed the EDNRB pathway in the context of Hirschsprung and pigmentation.

This neural crest connection is also the reason the incontinentia pigmenti and Blaschko’s lines patterns reviewed elsewhere on this site involve skin cell distribution: the cellular geography visible as brindle stripes follows the developmental history of neural crest-derived cells, even in a genetically different mechanism from EDNRB-based spotting.

Testing and management

The commercial test for frame overo (EDNRB Ile118Lys) is offered by the UC Davis Veterinary Genetics Laboratory, Animal Genetics (Florida), and several international laboratories. A heterozygous result means the horse carries one copy of the frame allele and should not be crossed with another frame carrier if the owner wants to avoid producing lethal-white foals. A homozygous wild-type result means the horse is a non-carrier. The test is recommended by the American Paint Horse Association for all paint and pinto horses before breeding, and it is available as part of multi-panel color tests from most equine genetic testing services.

Sources

• Metallinos DL, Bowling AT, Rine J. A missense mutation in the endothelin-B receptor gene is associated with Lethal White Foal Syndrome: an equine version of Hirschsprung disease. Mamm Genome. 1998;9(5):426-431. PubMed.
• Yang GC, Croaker D, Zhang AL, Manglick P, Cartmill T, Cass D. A dinucleotide mutation in the endothelin-B receptor gene is associated with lethal white foal syndrome (LWFS). Hum Mol Genet. 1998;7(4):795-801. PubMed.
• OMIA:000409-9796: Coat colour, frame overo, Equus caballus. Online Mendelian Inheritance in Animals. Accessed 2026-06-04.
• Santschi EM, Purdy AK, Valberg SJ, Vrotsos PD, Kaese H, Mickelson JR. Endothelin receptor B polymorphism associated with lethal white foal syndrome in horses. Mamm Genome. 1998;9(4):306-9. PubMed.
• Sponenberg DP, Bellone R. Equine Color Genetics. 4th ed. Wiley Blackwell; 2017. pp. 130–160 (frame overo and lethal white).

Somatic mosaicism is the presence of two or more genetically distinct cell populations within a single individual descended from one fertilized egg. The distinction matters for coat science: the variation is postzygotic (it arises during development, not from the parents), which separates somatic mosaicism mechanistically from chimerism, roan, and the forms of brindle that trace to stable inherited variants. A mosaic horse carries its own genetic plurality, assembled cell by cell in the embryo.

The definition

The canonical definition, verified from Wikidata entity Q755077 and the Wikipedia article “Mosaic (genetics)”: somatic mosaicism is the presence of two or more populations of cells with different genotypes in one individual who developed from a single fertilized egg. The postzygotic qualifier is load-bearing. Chimerism also produces genetically mixed tissue, but through a different mechanism: cell exchange between two separate embryos (or maternal-fetal microchimerism) rather than mutation within a single developing organism.

Synonyms in use: genetic mosaicism, clonal mosaicism, postzygotic mosaicism. These refer to the same phenomenon; the “somatic” qualifier specifies that the mosaic event is confined to body cells rather than germ cells (the heritable germline-mosaicism subtype is a related but distinct category, addressed below).

The mechanism

During early embryogenesis, cells divide rapidly and copy the genome at each division. Errors in that copying (a substitution, a deletion, a failure of chromosomal segregation, a retrotransposition event where a mobile element (LINE-1, Alu) inserts into a new genomic position) produce a daughter cell carrying a variant the parental cell did not. All daughters of that cell inherit the variant; the rest of the organism does not. The result is a clone with its own genetic instruction set embedded within the normal background.

The mutation types that generate mosaicism span the full genomic scale: single-nucleotide variants (SNVs), insertions and deletions, copy-number variants (CNVs), whole-chromosome aneuploidies, and retrotransposition events. Freed, Stevens, and Pevsner documented this range in a 2014 peer-reviewed review, noting that somatic variation spans “all genomic scales from point mutations to aneuploidies,” including retrotransposition and complex chromosomal rearrangements. (Freed, Stevens, Pevsner, Genes (Basel), 2014)

In coat-relevant terms: if the mutation strikes a melanocyte precursor (a cell committed to generating pigment cells) every descendant of that clone carries the altered pigmentation instruction. Melanocytes migrate from the neural crest through the developing skin, and the founding clone’s migration path determines where altered pigment appears. The result tends to follow body-axis streaks or whorls rather than the bilaterally symmetric markings produced by constitutionally inherited coat-color variants.

Timing governs distribution

Mutations occurring early in development affect a larger proportion of cells and typically produce more severe or widespread phenotypic effects. Later mutations affect fewer cells and produce focal or segmental patterns. Campbell, Shaw, Stankiewicz, and Lupski established this principle in a 2015 review: “mutations occurring early during development have the most meaningful impact on the phenotype.” (Campbell et al., Trends in Genetics, 2015) A mosaic coat that covers most of one side indicates an early embryonic event; a small irregular patch indicates a later one.

Somatic mosaicism is not rare: it is universal

Mosaicism is not an anomaly; it is the baseline state of multicellular organisms. Of 815 human preimplantation embryos analyzed, only 22% were fully diploid while 73% were already mosaic. (Freed et al., 2014) The same review states plainly that “every human is undoubtedly mosaic.” The relevant questions for any given individual are not whether mosaicism is present but which tissues carry which variants and whether any of those variants affect observable phenotype.

Age accumulates the burden. Neurons, sequenced post-mortem, carry approximately 16–17 single-nucleotide variants per genome per year; by age 70, individual neurons harbor roughly 1,000–2,000 somatic SNVs. Oligodendrocytes accumulate variants roughly 69% faster (~27/year). (Bizzotto, Frontiers in Neuroscience, 2023) In blood, clonal hematopoiesis (somatic mosaicism in the haematopoietic compartment) affects fewer than 0.1% of individuals before age 40, roughly 10% by age 70, and more than 50% of individuals older than 85 by unbiased deep sequencing. (Evans & Walsh, Physiological Reviews, 2022)

Why a blood test can miss a mosaic variant

Standard genotyping reads the average of all cells in the sample. If a mosaic clone comprises 15% of somatic cells, its variant allele appears at 15% frequency in a blood draw, below the threshold most genotyping pipelines flag as a heterozygous variant, and far below the 50% expected for a standard heterozygote. The horse tests as wild-type. The coat pattern says otherwise.

This is not an error in the assay; it is a limit of what bulk-tissue sampling captures. Sanger sequencing cannot reliably detect variants below 15–20% variant allele frequency (VAF). Next-generation sequencing (NGS) can detect somatic mosaicism down to 1–10% VAF. In a clinical cohort (CAUSES) of 500 parent-child trios, mosaicism was identified in 12 families representing 4.6% of diagnosed families; six of those cases were missed entirely by Sanger sequencing. (Cook et al., Cold Spring Harbor Molecular Case Studies, 2021) High-depth sequencing of a skin biopsy from within the affected area resolves variants that whole-blood sampling averages away.

Subtypes

Somatic mosaicism (body cells only) is generally not heritable because it does not affect the germ cells. The following subtypes are adjacent and must be distinguished:

• Germline mosaicism: the postzygotic mutation affects germ cells (eggs or sperm). The individual may be phenotypically normal while transmitting the variant to offspring. Somatically mosaic parents who carry the variant in germ tissue face recurrence risk estimated at two to three orders of magnitude higher than the general population. (Campbell et al., 2015)
• Gonosomal mosaicism: the variant affects both somatic and germline cells. Both phenotypic expression and transmission to offspring are possible.
• Revertant mosaicism: a pathogenic mutation spontaneously corrects itself in a somatic cell via back mutation, gene conversion, intragenic recombination, or a second-site compensatory mutation. This produces patches of phenotypically normal tissue amid affected tissue. Documented in epidermolysis bullosa, Wiskott-Aldrich syndrome, and ichthyosis with confetti, and has been termed “natural gene therapy.” Lai-Cheong, McGrath, and Uitto defined it as “spontaneous partial or complete reversal of an affected somatic cell or cells to a wild-type phenotype.” (Lai-Cheong, McGrath, Uitto, Trends in Molecular Medicine, 2010)

Conditions that can only exist in mosaic form

Some mutations are incompatible with life when present in every cell of the body (constitutional form), but survive when confined to a subset. Proteus syndrome is the paradigm: it is caused exclusively by mosaic activating mutations in the AKT1 gene. Campbell et al. note that “no constitutional mutations have been detected”: the whole-body version of the AKT1 activating mutation is lethal at the organismal level; only the mosaic form, where normal cells compensate for mutant ones, permits development to proceed. (Campbell et al., 2015) The same principle applies in principle to severe pigmentation mutations where the constitutional form is lethal and the mosaic form produces patchy coat phenotypes compatible with normal health.

Confusable patterns: what somatic mosaicism is not

Three related concepts produce similar-looking phenotypes through distinct mechanisms. Getting the mechanism right matters for coat science because the mechanism determines what a genetic test finds, what a breeding prediction can say, and which historical record applies.

• Chimerism: two genetically distinct cell populations arising from two original embryos (twin embryo fusion) or from maternal-fetal cell transfer. Chimerism is not a postzygotic mutation in one embryo; it is a merger of two embryos’ cells or a transfer across a placental boundary. The distinction matters for genetic testing: a chimeric horse may carry two full sets of alleles (two different complete genotypes) rather than a mosaic variant at low frequency against a normal background. The chimerism page covers this mechanism in full.
• Heteroplasmy: a mosaic variant in mitochondrial DNA rather than nuclear DNA. Mitochondria are maternally inherited and present in thousands of copies per cell; a pathogenic mtDNA variant may be present in some copies and absent in others within the same cell. Heteroplasmy is mitochondria-specific and is not the same as nuclear somatic mosaicism.
• Germline mosaicism (as confusable with de novo mutation): when a child is born with a variant not detected in either parent, standard interpretation is de novo constitutional mutation. But if the variant arose postzygotically in a parent’s germ cell lineage, the parent is a germline mosaic: phenotypically normal, variant absent from their blood, yet transmitting the pathogenic allele. This is not a de novo event in the child; it is an inherited event from an undetected mosaic parent.

Somatic mosaicism and brindle horses

The genetics of brindle coat patterning in horses remains unresolved. No single constitutional variant has been identified that reliably predicts brindle. Somatic mosaicism in melanocyte precursor populations is a mechanistic candidate consistent with several features of the documented cases: the pattern tends to be asymmetric and follows body-axis streaks; affected horses often have no family history of brindle; standard coat-color panels return no explanatory result; and the pattern does not segregate predictably through pedigrees the way Mendelian traits do.

These features are consistent with a postzygotic mutation explanation, but consistency is not confirmation. The specific somatic variants responsible for equine brindle patterning, if somatic mosaicism is the mechanism, have not been identified and reported in peer-reviewed literature as of the dossier date (2026-06-03). This is genuinely unresolved science. Claiming certainty here would be fabricating a conclusion the literature has not reached.

The 1997 archive at brindlehorses.com: an original catalogue of documented brindle coat cases assembled when mainstream genetics still classified these patterns as unexplained anomalies, is the primary historical record for this question. It predates the current mechanistic frameworks and its cases are exactly the kind of phenotypic primary source that mechanistic investigation requires. The cases documented there are real; the mechanism behind them is what remains open.

References

• Freed D, Stevens EL, Pevsner J. “Somatic Mosaicism in the Human Genome.” Genes (Basel). 2014;5(4):1064–1094. PMC4276927
• Campbell IM, Shaw CA, Stankiewicz P, Lupski JR. “Somatic mosaicism: implications for disease and transmission genetics.” Trends in Genetics. 2015;31(7):382–392. PMC4490042
• Lai-Cheong JE, McGrath JA, Uitto J. “Revertant mosaicism in skin: natural gene therapy.” Trends in Molecular Medicine. 2011;17(3):140–148. PMC3073671
• Bizzotto S. “Somatic Mutations in Single Human Neurons.” Frontiers in Neuroscience. 2023. PMC10213359
• Evans MA, Walsh K. “Clonal hematopoiesis, somatic mosaicism, and age-associated disease.” Physiological Reviews. 2023;103(1):649–716. PMC9639777
• Cook SA, et al. “Clinical exome sequencing identifies mosaicism in four point six percent of families.” Cold Spring Harbor Molecular Case Studies. 2021. PMC8751411
• Wikipedia: Mosaic (genetics)
• Wikidata: Q755077: mosaicism

Somatic mosaicism affects the entire organism during development, and when it alters pigment-producing cells the coat shows it. Skin-level anomalies that arise from cellular abnormality during development, including abnormal hair texture, patchy coat change, and unusual hair-loss patterns, are documented in detail at sickhorses.com’s guide to hair loss in horses, which covers the dermatological conditions that can be confused with developmental coat variation. On the genetics side, the foundational vocabulary for understanding how heritable variants move through populations is covered at horse-info.org’s entry on gene pool and the companion article on gene.

A brindle horse carries irregular vertical streaks running down its body and horizontally around its legs, concentrated on the neck, shoulders, and hindquarters, generally sparing the head [Wikipedia: Brindle]. The streaks may differ from the base coat in color, texture, or both; in horses carrying the heritable Brindle 1 mutation, the striped hair is distinctly less straight and more unruly than the surrounding coat, in addition to any color difference [Murgiano et al. 2016, G3]. Brindle is among the rarest coat patterns documented in the species [Wikipedia: Brindle], and most of the confusion about it follows from a single unchecked assumption: that it works the way brindle works in dogs.

It does not. Canine brindle is controlled by the K locus on chromosome 16, where the kbr allele produces alternating eumelanin and phaeomelanin zones across the coat [Kerns et al. 2007, Genetics]. Equine brindle has no K-locus equivalent. Three genetically distinct mechanisms are confirmed with peer-reviewed evidence in horses, none of which involves the K locus [Wikipedia: Brindle; Murgiano et al. 2016; Towers et al. 2013, PLOS ONE]. Which mechanism is in front of you determines whether the pattern is heritable, whether it carries any health implication, and what a breeding record should say about it.

Three confirmed mechanisms

Chimerism

Most documented brindle horses are chimeric: two separately fertilized embryos fused early in development, producing a single animal whose cells carry two distinct genotypes [Wikipedia: Brindle]. Where the two cell populations differ in coat color (one bay, one chestnut, for example) the boundary between them traces the paths along which pigment cells migrated during fetal development, producing the visual signature of vertical brindle stripes [Kathman, Equine Tapestry, 2024]. These developmental pathways were first described by dermatologist Alfred Blaschko around 1901 and are now called Blaschko’s lines [Kathman 2024].

Chimeric brindle is not heritable. The reproductive cells arise from one or the other of the two component genomes, not from a blend, so the foal inherits a single ordinary coat genotype with no trace of the pattern [Kathman 2024]. A chimera can be confirmed by finding two distinct genotypes from tissue samples taken at different sites, or by a parentage test that returns apparent mismatches (more than two alleles per locus), a result that signals two genomes where one was expected [OMIA:000393-9796, Tetragametic chimerism, Equus caballus]. A 2018 study of 21,097 Purebred Spanish horses found chimerism at roughly 0.011% prevalence and concluded it is not especially connected to infertility [Anaya et al. 2018, via ScienceDaily].

Brindle 1 (BR1): the heritable form

In 2016 a peer-reviewed study identified a heritable equine brindle: an intronic variant in the MBTPS2 gene (c.1437+4T>C; genomic position NC_009175.3:g.17286855T>C on EquCab3.0) on the X chromosome, confirmed in a family of American Quarter Horses [Murgiano, Waluk, Towers et al. 2016, G3: Genes|Genomes|Genetics, doi:10.1534/g3.116.032433; OMIA:002021-9796]. The variant disrupts splicing: roughly 20% of MBTPS2 transcripts in affected skin skip exon 10 and parts of exon 11, deleting 32 codons that encode parts of the protein’s luminal and transmembrane domains [Murgiano et al. 2016]. The variant co-segregated perfectly with the phenotype across 39 family members and was absent from 457 control horses spanning 17 breeds [Murgiano et al. 2016].

Inheritance is X-linked semidominant. Heterozygous mares (one copy of the mutation) display the characteristic striped coat with altered hair texture. Hemizygous males (one copy, no balancing X) show sparse mane and tail but no visible stripe pattern [Murgiano et al. 2016]. The MBTPS2 gene encodes a zinc metalloprotease involved in sterol homeostasis; mutations in its human orthologue cause three genodermatoses. The equine BR1 variant produces only coat and hair-texture change with no systemic pathology reported [Murgiano et al. 2016]. A commercial genetic test for BR1 is offered by the UC Davis Veterinary Genetics Laboratory; see what the BR1 result means for breeders [OMIA:002021-9796].

This is the central split most sources elide: chimeric brindle and BR1 brindle look alike on the coat and behave in opposite ways for breeding. A chimeric brindle mare routinely produces non-brindle foals; a BR1 heterozygous mare passes the variant to approximately half her daughters. A photograph cannot tell them apart. Laboratory testing can.

Incontinentia pigmenti: brindle with disease

A third X-linked cause produces brindle-like stripes in mares but is a distinct systemic disorder, not a coat pattern. Incontinentia pigmenti (IP) in horses results from a nonsense mutation in the IKBKG gene (c.184C>T; p.Arg62*), first documented in a family of Quarter Horses in 2013 [Towers et al. 2013, PLOS ONE, doi:10.1371/journal.pone.0081625; OMIA:001899-9796]. Affected heterozygous mares develop progressive skin lesions following Blaschko’s lines, along with dental and hoof abnormalities; hemizygous males are typically lethal in utero [OMIA:001899-9796]. IP was found in the same Quarter Horse family as the BR1 study; the distinguishing feature is the multi-system pathology absent in BR1 horses [Murgiano et al. 2016].

A horse with brindle-like stripes and concurrent hoof or dental anomalies warrants consideration of IP. A horse with the stripe pattern and no systemic signs warrants consideration of BR1 or chimerism. The visual overlap between the three is real; the clinical and genetic separation is clean once the relevant evidence is gathered.

What brindle is not

Several patterns produce a striped or mottled-looking horse that gets called brindle in the absence of a better word. Each is a separate thing.

Roan intermingles white and colored hairs evenly across the body while the head, mane, tail, and lower legs (the “points”) retain the base color [Wikipedia: Roan (horse); Wikidata Q1520693]. Roan is present at birth and does not progressively lighten with age, which distinguishes it from gray [Wikipedia: Roan (horse)]. The underlying locus maps to the KIT gene region on equine chromosome 3, but no definitive causal mutation has been identified [Everts et al. 2025, Animals (Basel) 15(12):1705]. Roan does not stripe; brindle does not frost. Holding a bay roan and a chimeric brindle side by side, the distinction is immediate.

Rabicano (also called white ticking) places white hairs at the flank-stifle junction and the base of the tail (the “skunk tail”) and may extend as faint ticking along the barrel ribs [Wikipedia: Rabicano; Wikidata Q2033416]. Rabicano occurs in breeds that carry no true roan gene, including the Arabian, where the registry formally calls it “roan” [Wikipedia: Rabicano]. Its genetic cause is unresolved; a 2022 UC Davis thesis identified a candidate haplotype on chromosome 28 surrounding KITLG but could not confirm the causal variant [Esdaile & Bellone, UC Davis eScholarship 2022]. No commercial genetic test exists. The diagnostic markers that separate rabicano from brindle are the location (flank and tail rather than distributed vertically across the trunk) and the character of the white hairs (individual ticked white hairs scattered into color, not dark streaks separating color zones).

Manchado is an extremely rare white-spotting pattern documented only in Argentina, appearing in Thoroughbred, Criollo, Polo Pony, Arabian, and Hackney horses [Wikipedia: Pinto horse, citing Sponenberg & Bellone, Equine Color Genetics, 4th ed. 2017]. The pattern presents as large crisp white areas with smooth round colored spots inside them; the head and legs typically remain dark, and a white tail is consistent [Wikipedia: Pinto horse]. The genetic cause is not confirmed; the leading hypothesis is a rare recessive allele, but the 2024 peer-reviewed review of white coat color in horses omits manchado entirely, confirming no causal gene has been published [McFadden et al. 2024, Animals (Basel)]. Manchado and brindle share only their rarity; one is patchwork spotting with interior colored islands, the other is vertical striping without discrete spots.

Somatic mosaicism (distinct from chimerism) results when a single embryo’s cell acquires a mutation during development; every cell descended from it carries the change, and the resulting marked region again follows Blaschko’s lines [Wikipedia: Mosaic (genetics); Wikidata Q755077]. A chimera begins as two embryos; a mosaic begins as one. Both produce coat patterning along Blaschko’s lines and both are generally non-heritable (somatic, not germline). The distinction requires molecular testing to establish; the practical breeding implication is the same: neither form reliably reproduces the pattern [Kathman 2024].

Open questions

The genetic basis of brindle in horses is only partially resolved. Three mechanisms are confirmed with peer-reviewed evidence: tetragametic chimerism [OMIA:000393-9796], heritable BR1 (MBTPS2 variant) [Murgiano et al. 2016], and IP (IKBKG variant) [Towers et al. 2013]. Additional brindle cases exist that have not been assigned to any of these three, and whether further heritable loci exist beyond BR1 is an open research question [Wikipedia: Brindle]. The BR1 study was conducted in a single Quarter Horse / Paint Horse family of 39 animals; breed prevalence outside that lineage is not established in the published literature [Murgiano et al. 2016]. The precise mechanistic boundary between non-IP, non-BR1 Blaschko-line pigmentation and the other two mechanisms has not been crisply drawn in the retrieved literature. These uncertainties are not defects in the record; they are the frontier of what has been tested.

The 1997 archive

This domain has catalogued brindle and unusual-coat horses since 1997, before the MBTPS2 and IKBKG variants were characterized and before chimerism in horses had been confirmed by DNA testing. The 1997 brindle horse archive is a primary record of documented individual horses, assembled when mainstream genetics still treated these patterns as curiosities rather than subjects of genetic inquiry. It is the historical evidentiary floor under the claims on this page, and it predates the sources that those claims cite. It is kept intact as a dated primary source, not revised or modernized: a stable artifact from a specific moment in the field’s understanding, which is exactly what makes it useful as a baseline.

References

• Murgiano L, Waluk DP, Towers R, et al. An Intronic MBTPS2 Variant Results in a Splicing Defect in Horses with Brindle Coat Texture. G3: Genes|Genomes|Genetics. 2016;6(9):2963–2970. doi:10.1534/g3.116.032433. PMC5015953
• Towers RE, Murgiano L, Millar DS, et al. A Nonsense Mutation in the IKBKG Gene in Mares with Incontinentia Pigmenti. PLOS ONE. 2013;8(12):e81625. doi:10.1371/journal.pone.0081625. Full text
• Kerns JA, Cargill EJ, Clark LA, et al. Linkage and Segregation Analysis of Black and Brindle Coat Color in Domestic Dogs. Genetics. 2007;176(3):1679–1689. PMC1931550
• Everts RE, et al. Novel Equine Roan Haplotypes and Prevalence of the RN1 and RN2 Haplotypes in Multiple Breeds. Animals (Basel). 2025;15(12):1705. PMC12189688
• McFadden A, et al. Spotting the Pattern: A Review on White Coat Color in the Domestic Horse. Animals (Basel). 2024. PMC10854722
• Anaya G, Fernandez ME, Valera M, et al. Prevalence of twin foaling and blood chimaerism in purebred Spanish horses. Vet J. 2018. Open summary via ScienceDaily
• Esdaile ES; advisor Bellone RR. Short Tandem Repeat Analysis of Genetic Diversity Metrics in American Standardbreds and an Investigation on the Cause of the Rabicano Coat Color Phenotype. UC Davis eScholarship, 2022. Full text
• Kathman L. Mosaicism in Horses – Part 1. Equine Tapestry. 2024-05-09. equinetapestry.com
• OMIA:002021-9796 – Brindle 1, Equus caballus. omia.org (last updated 2026-05-31)
• OMIA:001899-9796 – Incontinentia pigmenti, Equus caballus. omia.org
• OMIA:000393-9796 – Tetragametic chimerism (including Freemartin), Equus caballus. omia.org
• Wikipedia: Brindle. en.wikipedia.org/wiki/Brindle (Wikidata Q1969557)
• Wikipedia: Roan (horse). en.wikipedia.org/wiki/Roan_(horse) (Wikidata Q1520693)
• Wikipedia: Rabicano. en.wikipedia.org/wiki/Rabicano (Wikidata Q2033416)
• Wikipedia: Mosaic (genetics). en.wikipedia.org/wiki/Mosaic_(genetics) (Wikidata Q755077)
• Sponenberg DP, Bellone R. Equine Color Genetics, 4th ed. Wiley Blackwell, 2017. [Cited via Wikipedia Pinto horse article for manchado description]

For a comparison with a well-characterized spotting pattern that is definitively not brindle, the appaloosa LP complex (TRPM1) and the tobiano KIT inversion are covered separately. Manchado and pinto are both white-spotting categories that registries handle differently from brindle’s stripe-based patterns. The pinto grouping (which covers overo, tobiano, tovero, and several rarer pattern subtypes) is documented at horse-info.org’s pinto entry. For owners managing a horse whose striped or unusual coat raises questions about ongoing coat health, sickhorses.com’s article on hair loss in horses covers the dermatological and nutritional causes of coat change that can complicate visual assessment of a genetically patterned animal.

Blood chimerism arises specifically in dizygotic twins, making it a product of twinning rates that themselves vary by breed and breeding practice. The broader context of how cross-breed and within-breed reproduction shapes equine genetics is covered at horse-info.org’s interbreeding entry. A practical note for owners: a chimeric horse whose chimerism is discovered incidentally through a parentage test that returns anomalous results should have routine health monitoring continued without interruption. Colic is the most common acute health emergency in horses regardless of coat genetics, and sickhorses.com’s guide to colic symptoms, causes, and when to call a vet is a useful reference for any horse owner.